Correale J, Ysrraelit MC (2022) Multiple sclerosis and aging: the dynamics of demyelination and remyelination. ASN Neuro 14:17590914221118502. https://doi.org/10.1177/17590914221118502

Article  PubMed  PubMed Central  Google Scholar 

Gharagozloo M, Bannon R, Calabresi PA (2022) Breaking the barriers to remyelination in multiple sclerosis. Curr Opin Pharmacol 63:102194. https://doi.org/10.1016/j.coph.2022.102194

Article  CAS  PubMed  PubMed Central  Google Scholar 

Franklin RJM, Simons M (2022) CNS remyelination and inflammation: from basic mechanisms to therapeutic opportunities. Neuron 110(21):3549–3565. https://doi.org/10.1016/j.neuron.2022.09.023

Article  CAS  PubMed  Google Scholar 

Grassi S, Prinetti A (2025) How do different cell populations orchestrate Myelin regeneration? Biochem Soc Trans 53(3):653–669. https://doi.org/10.1042/BST20231085

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paz Soldan MM, Warrington AE, Bieber AJ, Ciric B, Van Keulen V, Pease LR, Rodriguez M (2003) Remyelination-promoting antibodies activate distinct Ca2 + influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of Myelin repair. Mol Cell Neurosci 22(1):14–24. https://doi.org/10.1016/s1044-7431(02)00018-0

Article  PubMed  Google Scholar 

Grassi S, Cabitta L, Prioni S, Mauri L, Ciampa MG, Yokoyama N, Iwabuchi K, Zorina Y, Prinetti A (2023) Identification of the lipid antigens recognized by rHIgM22, a remyelination-promoting antibody. Neurochem Res 48(6):1783–1797. https://doi.org/10.1007/s11064-023-03859-2

Article  CAS  PubMed  Google Scholar 

Podbielska M, Banik NL, Kurowska E, Hogan EL (2013) Myelin recovery in multiple sclerosis: the challenge of remyelination. Brain Sci 3(3):1282–1324. https://doi.org/10.3390/brainsci3031282

Article  CAS  PubMed  PubMed Central  Google Scholar 

Warrington AE, Rodriguez M (2008) Remyelination-promoting human igms: developing a therapeutic reagent for demyelinating disease. Curr Top Microbiol Immunol 318:213–239. https://doi.org/10.1007/978-3-540-73677-6_9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watzlawik J, Holicky E, Edberg DD, Marks DL, Warrington AE, Wright BR, Pagano RE, Rodriguez M (2010) Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes. Glia 58(15):1782–1793. https://doi.org/10.1002/glia.21048

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watzlawik JO, Warrington AE, Rodriguez M (2013) PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation. PLoS ONE 8(2):e55149. https://doi.org/10.1371/journal.pone.0055149

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grassi S, Giussani P, Prioni S, Button D, Cao J, Hakimi I, Sarmiere P, Srinivas M, Cabitta L, Sonnino S, Prinetti A (2019) Human remyelination promoting antibody stimulates astrocytes proliferation through modulation of the sphingolipid rheostat in primary rat mixed glial cultures. Neurochem Res 44(6):1460–1474. https://doi.org/10.1007/s11064-018-2701-x

Article  CAS  PubMed  Google Scholar 

Hakomori S (1990) Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem 265(31):18713–18716

Article  CAS  PubMed  Google Scholar 

Hakomori S, Igarashi Y (1995) Functional role of glycosphingolipids in cell recognition and signaling. J Biochem 118(6):1091–1103. https://doi.org/10.1093/oxfordjournals.jbchem.a124992

Article  CAS  PubMed  Google Scholar 

Zhou Q, Hakomori S, Kitamura K, Igarashi Y (1994) GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances Serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction. J Biol Chem 269(3):1959–1965

Article  CAS  PubMed  Google Scholar 

Tagami S, Inokuchi Ji J, Kabayama K, Yoshimura H, Kitamura F, Uemura S, Ogawa C, Ishii A, Saito M, Ohtsuka Y, Sakaue S, Igarashi Y (2002) Ganglioside GM3 participates in the pathological conditions of insulin resistance. J Biol Chem 277(5):3085–3092. https://doi.org/10.1074/jbc.M103705200

Article  CAS  PubMed  Google Scholar 

Prinetti A, Chigorno V, Prioni S, Loberto N, Marano N, Tettamanti G, Sonnino S (2001) Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro. J Biol Chem 276(24):21136–21145. https://doi.org/10.1074/jbc.M010666200

Article  CAS  PubMed  Google Scholar 

Riboni L, Prinetti A, Bassi R, Tettamanti G (1994) Formation of bioactive sphingoid molecules from exogenous sphingomyelin in primary cultures of neurons and astrocytes. FEBS Lett 352(3):323–326

Article  CAS  PubMed  Google Scholar 

McCarthy KD, de Vellis J (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85(3):890–902

Article  CAS  PubMed  Google Scholar 

Prinetti A, Basso L, Appierto V, Villani MG, Valsecchi M, Loberto N, Prioni S, Chigorno V, Cavadini E, Formelli F, Sonnino S (2003) Altered sphingolipid metabolism in N-(4-hydroxyphenyl)-retinamide-resistant A2780 human ovarian carcinoma cells. J Biol Chem 278(8):5574–5583. https://doi.org/10.1074/jbc.M207269200

Article  CAS  PubMed  Google Scholar 

Scandroglio F, Loberto N, Valsecchi M, Chigorno V, Prinetti A, Sonnino S (2009) Thin layer chromatography of gangliosides. Glycoconj J 26(8):961–973. https://doi.org/10.1007/s10719-008-9145-5

Article  CAS  PubMed  Google Scholar 

Vaskovsky VE, Kostetsky EY (1968) Modified spray for the detection of phospholipids on thin-layer chromatograms. J Lipid Res 9(3):396

Article  CAS  PubMed  Google Scholar 

Gault CR, Obeid LM, Hannun YA (2010) An overview of sphingolipid metabolism: from synthesis to breakdown. Adv Exp Med Biol 688:1–23. https://doi.org/10.1007/978-1-4419-6741-1_1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riboni L, Prinetti A, Bassi R, Tettamanti G (1991) Cerebellar granule cells in culture exhibit a ganglioside-sialidase presumably linked to the plasma membrane. FEBS Lett 287(1–2):42–46. https://doi.org/10.1016/0014-5793(91)80012-r

Article  CAS  PubMed  Google Scholar 

Howe CL, Bieber AJ, Warrington AE, Pease LR, Rodriguez M (2004) Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. Neurobiol Dis 15(1):120–131. https://doi.org/10.1016/j.nbd.2003.09.002

Article  CAS  PubMed  Google Scholar 

Chami M, Halmer R, Schnoeder L, Anne Becker K, Meier C, Fassbender K, Gulbins E, Walter S (2017) Acid Sphingomyelinase deficiency enhances Myelin repair after acute and chronic demyelination. PLoS ONE 12(6):e0178622. https://doi.org/10.1371/journal.pone.0178622

Article  CAS  PubMed  PubMed Central  Google Scholar 

Becker KA, Halmer R, Davies L, Henry BD, Ziobro-Henry R, Decker Y, Liu Y, Gulbins E, Fassbender K, Walter S (2017) Blockade of experimental multiple sclerosis by inhibition of the acid Sphingomyelinase/Ceramide system. Neuro-Signals 25(1):88–97. https://doi.org/10.1159/000484621

Article  PubMed  Google Scholar 

Eisen A, Greenberg BM, Bowen JD, Arnold DL, Caggiano AO (2017) A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis. Mult Scler J Exp Transl Clin 3(4):2055217317743097. https://doi.org/10.1177/2055217317743097

Article